Adenyldeoxyriboside en es it fr

Adenyldeoxyriboside Brand names, Adenyldeoxyriboside Analogs

Adenyldeoxyriboside Brand Names Mixture

  • No information avaliable

Adenyldeoxyriboside Chemical_Formula


Adenyldeoxyriboside RX_link

Adenyldeoxyriboside fda sheet

Adenyldeoxyriboside FDA

Adenyldeoxyriboside msds (material safety sheet)

Adenyldeoxyriboside MSDS

Adenyldeoxyriboside Synthesis Reference

No information avaliable

Adenyldeoxyriboside Molecular Weight

267.242 g/mol

Adenyldeoxyriboside Melting Point

235.5 oC

Adenyldeoxyriboside H2O Solubility

8230 mg/L

Adenyldeoxyriboside State


Adenyldeoxyriboside LogP


Adenyldeoxyriboside Dosage Forms


Adenyldeoxyriboside Indication

For controlling paroxysmal supraventricular tachycardia (PSVT). This drug can also be used diagnostically for stable, wide complex tachyardias of unknown type.

Adenyldeoxyriboside Pharmacology

Adenosine is an endogenous nucleoside occurring in all cells of the body and is not chemically related to other antiarrhythmic drugs. Adenosine is indicated for the conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). Adenosine is antagonized competitively by methylxanthines such as caffeine and theophylline, and potentiated by blockers of nucleoside transport such as dipyridamole. Adenosine is not blocked by atropine.

Adenyldeoxyriboside Absorption

No information avaliable

Adenyldeoxyriboside side effects and Toxicity

No information avaliable

Adenyldeoxyriboside Patient Information

No information avaliable

Adenyldeoxyriboside Organisms Affected

Humans and other mammals